Actve is on a mission to change the way people connect with their favourite fitness creators. The company aspires to help creators earn an income and build a subscription business. Actve asserts that it caters to a variety of creator needs allowing them to live-stream their workouts, offer guided programs to customers, or use Actve's software to manage their clients. The company aims to become a contender in the digital fitness market that is projected to be worth £21 billion by 2022. It aims to launch its platform in September 2021. Actve will use the investment to develop its platform, hire key staff, build its user base, and work towards becoming an industry champion for fitness creators.
days to go:
Expired
investment:
£165,627
WhatsInStore is the best way to shop for deals to save time, money and energy. It is the world’s first AI engine (patent pending) that empowers shoppers to make buying decisions by sending information to the user’s phone about the products they are interested in. WhatsInStore will focus specifically on the UK grocery market, which has a potential of 28 million shoppers. There are 87,041 physical outlets selling groceries in the UK and the company has signed up with 23 retail stores so far. The complete system has been built and is fully operational. The company has approval for SEIS and EIS tax scheme for the investors. The money invested will be used to grow the user base, secure more retailers, promote via predominantly social media and sell subscriptions to retailers
days to go:
Expired
investment:
£51,500
A secure digital platform that lets extended family members follow a pupil’s journey through their school yearsSocial networks are big business in the networked world that we live in today. Acknowledge Xc’s new online digital platform harnesses the power of existing school websites, enabling a pupil’s family members to follow their years at school.Having collaborated with top schools including Eton, Berkhamstead, Wellington College, Stowe School and Steiner Schools, Acknowledge is looking for investment to complete the build of its internet-based platform.As the platform is in the later stages of development, the company has already had a significant amount of collaborative input from schools and parents.Pupils jointly create profiles with their school, publishing videos, pictures and events relating to academic achievements and extra curriculum interests that could otherwise go unnoticed. Access is granted to extended family using secure methods, allowing these members to log in, view and even comment on a pupil’s activity. An additional feature of this platform is that each profile can be used to supplement a pupil’s academic CV and enhance applications for different schools. It acts as proof of past commitments and extra curricular activities and can support personal statements.The key market for Acknowledge is the independent schools sector in the UK which has around 500,000 pupils in 1200 schools. The company also has plans for expansion into overseas markets, and has estimated this market to contain around 3 million pupils – a figure which looks set to double by 2022. A revenue share scheme is in place to reward schools with a charitable donation and a referral fee is in place to reward those who help the model grow quickly. The first 10 founder schools will also receive more rewards.
days to go:
Expired
investment:
£29,800
Novai is a UK biotechnology company, developing and commercialising transformational technology in ophthalmology. The company's initial focus is on ophthalmic disorders such as glaucoma and AMD (Age-related Macular Degeneration). Novai argues that current clinical endpoints lack early disease biomarkers to objectively detect and measure cell health and response to treatment in the retina. Novai asserts that its proprietary biological marker, DARC (Detection of Apoptosis in Retinal Cells), combined with its bespoke and patented Artificial Intelligence (AI) aided algorithm, allows, for the first time in vivo, identification of cellular-level disease activity in the retina. Novai stresses that DARC can also predict disease progression, allowing for enrichment of clinical trial cohorts. The company anticipates an exit via licensing of its biomarker business to a Contract Research Organisation (CRO), an Initial Public Offering (IPO) following a successful phase 3 trial of the diagnostic platform, or trade sale to a strategic pharmaceutical company.
days to go:
Expired
investment:
£1,314,967
Docandu is an innovative digital health platform designed both for patients & doctors, making digital healthcare accessible from anywhere. Docandu aims to be a key tech health service provider, starting from Greece, improving the existing national and private health care services. The global digital health market is estimated to be worth $536 Billion by 2025. To date, they have developed two separate apps for doctors and patients. They have also received an angel investment of 100,000 Euros and sponsorship of $25,000 from Microsoft. The company has initiated early-stage relationships with a couple of Greek public and private health entities. With the proceeds, they will execute their go-to-market strategy and make global health ID a reality, by expanding its affiliate network of doctors, health providers and public health systems.
days to go:
Expired
investment:
£70,900
Paradym is an emotional intelligence (EI) coaching application. After identifying EI as the pillar of happiness and wellness, Paradym app has been designed to help people live their fullest and happiest lives and, in turn, promotes both their personal growth and wellbeing. Since its launch in 2018, it has signed a contract with Quiqup, its first B2B client and joined WeWork incubator, giving it access to 300k members. Moreover, it has also seen organic growth in its user base and in its international reach. Paradym's plan for 2019 is to increase its user base by investing in marketing and developing content to trigger sponsored content and product revenue. Its immediate revenue focus is 10% of the UK startup market which stands at £240M.
days to go:
Expired
investment:
£430,360
Cornerford aim to bring quality watches and accessories to the modern day gentleman, Cornerford was founded by engineer Dovy Cornerford. All Cornerford products are designed, manufactured or hand finished in the UK.
days to go:
Expired
investment:
£5,450
Plant-based diets, health and fitness programmes for those interested in veganism to improve their health and wellbeing. Skinny Bitch's book has sold more than 1.1m copies and is available in 6 languages. Readers of the book include celebrities such as Eva Longoria and Jessica Alba. Ellen DeGeneres has stated that the Skinny Bitch book is the reason she became vegan.
The company is now expanding their brand further by offering their content through online guides and blogs. Skinny Bitch is also intending to generate revenue via vegan supplements produced in the US to be sold through their website and third party e-commerce channels.
days to go:
Expired
investment:
£75,810
WorkClub converts under-used real estate into productive co-working areas and provides an affordable membership for remote workers across London. The company has 500+ members, 800+ guests and 25 WorkClub’s spaces in London. WorkClub has also secured many venues across the UK with Young's, Hippo Inns and more. Furthermore, it is listed as a ‘Top 10 startup to watch’ by TechRound, has 4.8* rating on TrustPilot and, acquired 30 businesses to offer discounted WorkClub memberships to members including ZipCar, PureGym. The company will use the funds to develop WorkClub’s technology and to expand its offering into other key UK cities.
days to go:
Expired
investment:
£342,820
Medics2You's is a hybrid telehealth platform that connects patients with healthcare experts around the globe with focus on Africa through a smart device from anywhere, six days a week. The company has a pilot project underway in Nigeria, a nation which spends $500m-1bn annually on outbound healthcare tourism. Medics2You aims to reach out to over 100m people unable to access quality healthcare. Medics2You's partnership with Lantum has given the company access to 18000+ doctors and 3000 clinicians. The funds will be used to create the web portal, expand the team, set up local centres, and enhance marketing activities.
days to go:
Expired
investment:
£156,370
